C. Martínez Chamorro

Bosutinib for pretreated patients with chronic phase chronic myeloid leukemia: primary results of the phase 4 BYOND study

U. Olsson‐Strömberg, T. Brümmendorf, S. Schmidt, 2020, Leukemia.

Bendamustine as salvage treatment for patients with relapsed or refractory mantle cell lymphoma patients: a retrospective study of the Spanish experience

C. Panizo, E. Domingo-Domènech, R. Arranz, 2014, Annals of Hematology.

Impact of the subcutaneous formulations of trastuzumab and rituximab on efficiency and resource optimization in Spanish hospitals: H-Excelencia study

A. Salar, J. García Mata, J. Bayo, 2021, BMC Health Services Research.